ViaMe One place. Endless possibilities.

A world of communities
to suit all of your interests.

  

All in one place.

  

Total Control.

Create multiple profiles.
Customize your layouts.
Manage contacts, feeds & widgets.

You decide who sees what.

  

Publish anything.

Blogs, articles, reports,
newsletters and more...

  

Interact anytime.

Communicate & collaborate
in real-time.

  

Share what you want
when you want.

Photos, videos, documents,
contacts and more.

  

What's in your space?
Get Started...

It's all about you and what
you wanna do.

  

Sign Up Now!

It's FREE and anyone can join.



Latest Picks
Buy Long DRL
Picked By da4ssassin
Jan 26, 2012 11:54 AM PST
Pick Allocation Price Last Change
DRL (L) 20% $1.38 $1.34 -$0.04  -2.90%
 0  Comment(s)
Rating N/A
Buy Long AMEL
Picked By lokaroo
Jan 25, 2012 4:50 AM PST
Pick Allocation Price Last Change
AMEL (L) 10% $0.09 $0.09 $0.00  0.00%
 0  Comment(s)
Rating N/A
Buy Long PLG
Picked By lokaroo
Jan 25, 2012 4:49 AM PST
Pick Allocation Price Last Change
PLG (L) 10% $1.10 $1.12 $0.02  1.82%
 0  Comment(s)
Rating N/A
Buy Long FTWR
Picked By lokaroo
Jan 25, 2012 4:48 AM PST
Pick Allocation Price Last Change
FTWR (L) 10% $0.36 $0.19 -$0.17  -47.31%
 0  Comment(s)
Rating N/A
Buy Long FROG
Picked By stmontalvo
Jan 24, 2012 8:37 PM PST
Pick Allocation Price Last Change
FROG (L) 10% $0.30 $0.28 -$0.02  -5.08%
 0  Comment(s)
Rating N/A
Get More: Latest Picks
Latest Picks
Latest Blog Posts
26
Thu
Caterpillar’s Q4 Profit Soars (CAT)
By Peter Cleveland
Jan 26, 2012 11:16 PM PST
Caterpillar posted strong fourth-quarter financial results and also provided a bullish outlook for 2012.
 0  Comment(s)
Rating N/A
25
Wed
Apple Reports Blowout Quarter (AAPL)
By Mark Spencer
Jan 25, 2012 8:55 AM PST
Apple Inc. has delivered a blowout quarter, posting record revenue and profit on the back of surging iPhone 4S sales.
 0  Comment(s)
Rating N/A
25
Wed
Amarantus (AMBS): Leading the Charge to Defeat Cell Apoptosis
By stockMark
Jan 25, 2012 8:20 AM PST
Amarantus Biosciences Inc. (OTCBB: AMBS) is a development-stage biotechnology company, similar to companies like Zalicus Inc. (NASDAQ: ZLCS) and Exelixis Inc. (NASDAQ: EXEL), that is pioneering the study of preventing cell apoptosis or cell death. From its...
 0  Comment(s)
Rating N/A
25
Wed
Should You Bet on Medical Device Stock DexCom Being an Acquisition Target? MDT, DXCM
By John Udovich
Jan 25, 2012 4:23 AM PST
A closer look at Terrence Gregg, the CEO of medical device stock DexCom (NASDAQ: DXCM).
» Read More
 0  Comment(s)
Rating N/A
24
Tue
Fed Forecast
By MTnews
Jan 24, 2012 1:32 PM PST
Daily Market Commentary for January 24, 2012 On Wednesday, after months of preparation, the Federal Reserve will reveal its own facelift that has economists sitting on the edge of their seats, awaiting the Fed forecast. (read more at Millennium-Traders.Com...
 0  Comment(s)
Rating N/A
Get More: Latest Blog Posts
Latest Blog Posts
Latest Analysis
Retire Rich
Symbol(s): LSTG
By Bosko Markoski
Jan 19, 2012 5:23 AM PST
Buy this now. This stock could bank roll your retirement. Dont work to live. Live to invest. That way you will Retire a very Happy MAN or WOMAN. GOOD LUCK IN 2012....
Action Recommendation
No Action Strong Buy
Timeframe Risk
Long-Term Low
 0  Comment(s)
Rating N/A
DexCom (DXCM) Has the Right Technology at the Right Time
Symbol(s): DXCM
By SmallCap Network
Jan 18, 2012 8:48 AM PST
DexCom, Inc. (NASDAQ:DXCM) is ready to rock, for a lot of reasons.
Action Recommendation
Upgrade Strong Speculative Buy
Timeframe Risk
Long-Term Medium
 0  Comment(s)
Rating N/A
MagicJack VocalTec Ltd (CALL): The Game-Changer Nobody Saw Coming
Symbol(s): CALL
By SmallCap Network
Jan 18, 2012 12:37 AM PST
magicJack VocalTec Ltd (NASDAQ:CALL) creates the right technology at the right time for the right price.
Action Recommendation
Upgrade Strong Speculative Buy
Timeframe Risk
Long-Term Medium
 0  Comment(s)
Rating N/A
BioPorto A/S - Analyst Initiation.
Symbol(s): BIOPOR.CO
By fillandkill
Jan 8, 2012 1:35 PM PST
It is very gratifying that the first analyst initiates coverage of BioPorto, with a strong BUY recommendation and a price target of 16.7, ie. an upside of 125%.The analysis can be found by using google, seach" proinvestor +stock inition report"I was very positively...
Action Recommendation
Upgrade Strong Buy
Timeframe Risk
Long-Term Low
 0  Comment(s)
Rating 1
Now is the time to buy RXPC on a strong speculative buy.
Symbol(s): RXPC
By rickycheers
Dec 21, 2011 4:32 AM PST
As long as I've been in it with RXPC I belive this is the best time if any to invest in this company. Future looks bright as long as the marketing team does their job this time.
Action Recommendation
Upgrade Strong Speculative Buy
Timeframe Risk
Long-Term High
 0  Comment(s)
Rating N/A
Get More: Latest Analysis
Latest Analysis
Latest Uploads
012712-BNVI, KOOL, AMLN
Uploaded By James E. Brumley
Jan 27, 2012 1:17 PM PST
FileName: 012712-kool.gif
FileSize: 14.69 KBs
MimeType: image/gif; charset=binary
 0  Comment(s)
Rating N/A
012712-BNVI, KOOL, AMLN
Uploaded By James E. Brumley
Jan 27, 2012 1:17 PM PST
FileName: 012712-amln.gif
FileSize: 9.53 KBs
MimeType: image/gif; charset=binary
 0  Comment(s)
Rating N/A
012712-BNVI, KOOL, AMLN
Uploaded By James E. Brumley
Jan 27, 2012 1:17 PM PST
FileName: 012712-bnvi.gif
FileSize: 9.78 KBs
MimeType: image/gif; charset=binary
 0  Comment(s)
Rating N/A
012612-oxgn
Uploaded By James E. Brumley
Jan 26, 2012 11:52 AM PST
FileName: 012612-oxgn-weekly.gif
FileSize: 12.24 KBs
MimeType: image/gif; charset=binary
 0  Comment(s)
Rating N/A
012612-oxgn
Uploaded By James E. Brumley
Jan 26, 2012 11:52 AM PST
FileName: 012612-oxgn-daily.gif
FileSize: 15.26 KBs
MimeType: image/gif; charset=binary
 0  Comment(s)
Rating N/A
Get More: Latest Uploads
Latest Uploads
Latest Articles
And On a Friday, No Less! BNVI, KOOL, and AMLN Off and Running
By James E. Brumley
Jan 27, 2012 1:19 PM PST
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), Bionovo Inc. (NASDAQ:BNVI), and ThermoGenesis Corp. (NASDAQ:KOOL) have made surprising progress at a time when it's least expected.
 0  Comment(s)
Rating N/A
Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials (LPTN)
By Mark Spencer
Jan 27, 2012 11:55 AM PST
Lpath Inc. is a San Diego-based therapeutic antibody company.
 0  Comment(s)
Rating N/A
A Phoenix Rises from the Ashes in Home Health Care (PINK:KADR)
By Dennis Askew
Jan 27, 2012 11:06 AM PST
Getting Out from Under a Dark Cloud.
 0  Comment(s)
Rating N/A
Two Copper Run-Ups Continue in a Flat Market (ARREF, CSFFF)
By Dennis Askew
Jan 27, 2012 9:42 AM PST
Strong 2012 Guidance Fuels Surge.
 0  Comment(s)
Rating N/A
North Springs Resources Provides Update on Drill Program at Goldstar Property (NSRS)
By Ed Liston
Jan 27, 2012 9:08 AM PST
North Springs Resources Corp. provided an update on its drill program at the Goldstar Property.
 0  Comment(s)
Rating N/A
Get More: Latest Articles
Latest Articles

Copyright © 2008-2009 Levelogic, Inc. All rights reserved.